Rights and permissions
About this article
Cite this article
First-line rituximab maintenance favourable in Finland. Pharmacoecon. Outcomes News 632, 7 (2011). https://doi.org/10.2165/00151234-201106320-00016
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-201106320-00016